Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc adjunctive therapy for major depressive disorder
MOH_2023-12-14_013109Phase 2Not yet recruiting
- Sponsor
- ד"ר אורן טנא
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of maraviroc in major depressive disorder (MDD) (2 arms), sponsored by ד"ר אורן טנא. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
maraviroc
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on MOH_2023-12-14_013109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-12-14_013109.